Atherogenesis in rheumatology

S. I. van Leuven; J. J. P. Kastelein; D. P. D'Cruz; G. R. Hughes; E. S. Stroes

doi:https://doi.org/10.1191/0961203306lu2273rr

Atherogenesis in rheumatology

S. I. van Leuven, J. J. P. Kastelein, D. P. D'Cruz, G. R. Hughes, E. S. Stroes

Research output: Contribution to journal › Review article › Academic › peer-review

31 Citations (Scopus)

Abstract

Atherosclerosis is a chronic inflammatory disorder characterized by immune cell activation, inflammation driven plaque formation and subsequent destabilization. In other disorders of an inflammatory nature, the chronic inflammatory state per se has been linked to acceleration of the atherosclerotic process which is underlined by an increased incidence of cardiovascular disease (CVD) in disorders such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and antiphopholipid (Hughes) syndrome (APS). In addition to systemic inflammation, additional mechanisms have been put forward that are more specific for the pathophysiology of the individual chronic inflammatory disorders

Original language	English
Pages (from-to)	117-121
Journal	Lupus
Volume	15
Issue number	3
DOIs	https://doi.org/10.1191/0961203306lu2273rr
Publication status	Published - 2006

Access to Document

https://doi.org/10.1191/0961203306lu2273rr

Cite this

@article{0219a20b56304945b800b50d8daf9081,

title = "Atherogenesis in rheumatology",

abstract = "Atherosclerosis is a chronic inflammatory disorder characterized by immune cell activation, inflammation driven plaque formation and subsequent destabilization. In other disorders of an inflammatory nature, the chronic inflammatory state per se has been linked to acceleration of the atherosclerotic process which is underlined by an increased incidence of cardiovascular disease (CVD) in disorders such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and antiphopholipid (Hughes) syndrome (APS). In addition to systemic inflammation, additional mechanisms have been put forward that are more specific for the pathophysiology of the individual chronic inflammatory disorders",

author = "{van Leuven}, {S. I.} and Kastelein, {J. J. P.} and D'Cruz, {D. P.} and Hughes, {G. R.} and Stroes, {E. S.}",

year = "2006",

doi = "https://doi.org/10.1191/0961203306lu2273rr",

language = "English",

volume = "15",

pages = "117--121",

journal = "Lupus",

issn = "0961-2033",

publisher = "SAGE Publications Ltd",

number = "3",

}

TY - JOUR

T1 - Atherogenesis in rheumatology

AU - van Leuven, S. I.

AU - Kastelein, J. J. P.

AU - D'Cruz, D. P.

AU - Hughes, G. R.

AU - Stroes, E. S.

PY - 2006

Y1 - 2006

N2 - Atherosclerosis is a chronic inflammatory disorder characterized by immune cell activation, inflammation driven plaque formation and subsequent destabilization. In other disorders of an inflammatory nature, the chronic inflammatory state per se has been linked to acceleration of the atherosclerotic process which is underlined by an increased incidence of cardiovascular disease (CVD) in disorders such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and antiphopholipid (Hughes) syndrome (APS). In addition to systemic inflammation, additional mechanisms have been put forward that are more specific for the pathophysiology of the individual chronic inflammatory disorders

AB - Atherosclerosis is a chronic inflammatory disorder characterized by immune cell activation, inflammation driven plaque formation and subsequent destabilization. In other disorders of an inflammatory nature, the chronic inflammatory state per se has been linked to acceleration of the atherosclerotic process which is underlined by an increased incidence of cardiovascular disease (CVD) in disorders such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and antiphopholipid (Hughes) syndrome (APS). In addition to systemic inflammation, additional mechanisms have been put forward that are more specific for the pathophysiology of the individual chronic inflammatory disorders

U2 - https://doi.org/10.1191/0961203306lu2273rr

DO - https://doi.org/10.1191/0961203306lu2273rr

M3 - Review article

C2 - 16634362

SN - 0961-2033

VL - 15

SP - 117

EP - 121

JO - Lupus

JF - Lupus

IS - 3

ER -